Skip to main content
U.S. flag

An official website of the United States government

Return to Search

CY 2009 Formulary Enhancement Window and Marketing Information

Guidance for Part D sponsors about enhancing their Part D formularies (limited to enhancements) prior to the Annual Coordinated Election Period, modifying applicable prior authorization (PA) and/or step therapy (ST) criteria, and adding newly approved drugs outlined in the CY 2009 Call Letter.

Download the Guidance Document


Issued by: Centers for Medicare & Medicaid Services (CMS)

Issue Date: September 19, 2008

DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.